ロード中...

A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria

Fansimef is a combination of 250 mg mefloquine (base), 500 mg sulfadoxine, and 25 mg pyrimethamine per tablet. One hundred and fifty adult male Brazilian patients at Belém (Pará), who had peripheral blood smears positive for Plasmodium falciparum, with or without clinical symptoms of falciparum mala...

詳細記述

保存先:
書誌詳細
主要な著者: de Souza, J. M., Sheth, U. K., Wernsdorfer, W. H., Trigg, P. I., Doberstyn, E. B.
フォーマット: Artigo
言語:Inglês
出版事項: 1987
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2490994/
https://ncbi.nlm.nih.gov/pubmed/3311438
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!